Luye Pharma to provide investors with a dose of diversification
Luye Pharma Group started premarketing an $800m Hong Kong IPO on June 11 and those on the deal are confident investor demand will be red hot.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: